Home > Balance Sheet > AJANTA PHARMA

AJANTA PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

AJANTA PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹42 Cr₹41 Cr₹177 Cr₹285 Cr₹275 Cr

What is the latest Total Non-Current Liabilities ratio of AJANTA PHARMA ?

The latest Total Non-Current Liabilities ratio of AJANTA PHARMA is ₹42 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹42 Cr
Mar2024₹41 Cr
Mar2023₹177 Cr
Mar2022₹285 Cr
Mar2021₹275 Cr

How is Total Non-Current Liabilities of AJANTA PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹42 Cr
3.21
Mar2024 ₹41 Cr
-76.99
Mar2023 ₹177 Cr
-37.77
Mar2022 ₹285 Cr
3.81
Mar2021 ₹275 Cr -

Compare Total Non-Current Liabilities of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹35,966.8 Cr -2.3% -3.3% 9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,645.0 Cr 2.9% 3.6% 0.2% Stock Analytics
DIVIS LABORATORIES ₹159,625.0 Cr 0.6% -4.5% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,415.0 Cr 2.1% -0.4% 31.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,480.0 Cr 0.4% -6.2% -19.4% Stock Analytics


AJANTA PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

-2.3%

-3.3%

9%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses